Finally, one should also consider other major determinants of ACS outcomes, namely concomitant diseases like diabetes, hypertension, congestive heart failure, etc., and the use of secondary preventive drugs like angiotensin converting enzyme inhibitors, β-blockers, statins, and platelets inhibitors [39]. This evidence concerns the gene ACE and hypertensive disorder.